Background and Aim: Morbidity and mortality from non-communicable diseases, particularly diabetes are increasing rapidly in Pakistan, the prevalence has reached 17.1%. A strong association has been witnessed between type II diabetes mellitus with atherosclerosis and serum uric acid level. The current study aim was to assess the levels of serum uric acid in type II diabetes mellitus. Materials and Methods: This cross-sectional study was carried out on 85 diagnosed patients of type II diabetes mellitus in Diabetes hospital, Peshawar and the Department of General Medicine, Shaikh Zayed Medical Complex, Lahore during the period from March 2020 to August 2020.Type II diabetes mellitus (DM) diagnosed patients 85 and healthy control 30 were evaluated in this study. The level of hyperuricemia was defined for women > 6 mg/dl and men >7 mg/dl in men. Results: In this study, a total of 85 diabetic diagnosed patients and 30 healthy controls were enrolled. No significant differences were there in the baseline characteristics like anthropometric and socio-demographic parameters. The mean age for diagnosed and control cases was 58.6 +/- 8.7 and 56.5 +/- 7.6 years with an age range of 40 and 80 years. Hyperuricemia proportion among diabetic patients was 12.13% while none of the control cases had hyperuricemia. The uric acid means level increased from 4.29 +/- 0.81 mg/dl with a diabetic duration between 3 and 4 years to 4.59 +/- 0.99 mg/dl with a diabetic duration of 5 to 7 years. Furthermore, mean serum uric acid level reached 6.50 +/- 1.08 in cases with diabetic duration 8 to 12 years. Statistically, a significant association was found between diabetic duration and serum uric acid. Also, a positive correlation was found in hyperlipidemia, serum uric acid levels, and hypertension. Conclusion: In diabetic patients serum uric acid levels were found to be significantly higher. Diabetic patients had hypertension, elevated serum uric acid levels, and high triglycerides with dyslipidemia. The rise in serum uric acid levels is proportional to the duration of diabetes.
机构:
Univ Sumatera Utara, Fac Med, Dept Internal Med, Div Endocrinol & Metab Dis, Jl Dr Mansyur 5, Medan 20155, Sumatera Utara, IndonesiaUniv Sumatera Utara, Fac Med, Dept Internal Med, Div Endocrinol & Metab Dis, Jl Dr Mansyur 5, Medan 20155, Sumatera Utara, Indonesia
Hidayat, Muhammad Fahmi
Syafril, Santi
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sumatera Utara, Fac Med, Dept Internal Med, Div Endocrinol & Metab Dis, Jl Dr Mansyur 5, Medan 20155, Sumatera Utara, IndonesiaUniv Sumatera Utara, Fac Med, Dept Internal Med, Div Endocrinol & Metab Dis, Jl Dr Mansyur 5, Medan 20155, Sumatera Utara, Indonesia
Syafril, Santi
Lindarto, Dharma
论文数: 0引用数: 0
h-index: 0
机构:
Univ Sumatera Utara, Fac Med, Dept Internal Med, Div Endocrinol & Metab Dis, Jl Dr Mansyur 5, Medan 20155, Sumatera Utara, IndonesiaUniv Sumatera Utara, Fac Med, Dept Internal Med, Div Endocrinol & Metab Dis, Jl Dr Mansyur 5, Medan 20155, Sumatera Utara, Indonesia
机构:
W Virginia Univ, Dept Community Med, Sch Med, Morgantown, WV 26506 USAW Virginia Univ, Dept Community Med, Sch Med, Morgantown, WV 26506 USA
Bandaru, Pavani
Shankar, Anoop
论文数: 0引用数: 0
h-index: 0
机构:
W Virginia Univ, Dept Community Med, Sch Med, Morgantown, WV 26506 USA
W Virginia Univ, Dept Med, Sch Med, Morgantown, WV 26506 USAW Virginia Univ, Dept Community Med, Sch Med, Morgantown, WV 26506 USA
机构:
Nihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, Japan
Nishida, Yayoi
Takahashi, Yasuo
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, Japan
Takahashi, Yasuo
Susa, Norio
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, Japan
Susa, Norio
Kanou, Nobukazu
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Biomed Sci, Div Pharmacol,Itabashi Ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, Japan
Kanou, Nobukazu
Nakayama, Tomohiro
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Lab Med,Itabashi Ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, Japan
Nakayama, Tomohiro
Asai, Satoshi
论文数: 0引用数: 0
h-index: 0
机构:
Nihon Univ, Sch Med, Dept Biomed Sci, Div Pharmacol,Itabashi Ku, Tokyo 1738610, JapanNihon Univ, Sch Med, Clin Trials Res Ctr, Div Genom Epidemiol & Clin Trials,Itabashi Ku, Tokyo 1738610, Japan